Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Natalizumab induction and maintenance therapy for Crohn's disease.
Sandhoff Disease
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Natalizumab induction and maintenance therapy for Crohn's disease.
Natalizumab induction and maintenance therapy for Crohn's disease. N Engl J Med. 2005 Nov 03; 353(18):1912-25.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Cell Adhesion Molecules
Crohn Disease
Double-Blind Method
Female
Humans
Immunosuppressive Agents
Integrin alpha Chains
JC Virus
Leukoencephalopathy, Progressive Multifocal
Male
Natalizumab
Remission Induction
Treatment Outcome
authors with profiles
Stephen B. Hanauer